PEORIA, Ariz. -- Commissioner Bud Selig has talked with union head Donald Fehr since the death of Steve Bechler, but wants to wait for autopsy results before making any more comments about ephedra.

There have been "significant discussions'' with Fehr, Selig said Saturday at the Seattle-San Diego game.

"What we're going to do now is wait for the reports of the autopsy and then we'll discuss it,'' he said. "I think what's important now is to wait for those results and then we'll decide how to proceed.''

"But until we get the results of the autopsy, then I don't think it's appropriate for me to comment any further,'' he said. "A young man has died and I'd just as soon find out what the cause was rather than sit here and do a lot of speculating.''

On Monday, Selig announced he was going to ban the use of ephedra in the minors. The major league players' union opposes such a ban.

Selig said he acted in banning ephedra with the minor leaguers because he could do it.

"We felt that it was the right thing to do,'' he said. "There was no question in my mind. We did it where we could do it and I'm glad we did it.''

In Fort Lauderdale, Fla., Saturday, Orioles outfielder Jay Gibbons said he likes the idea of placing stronger warning labels on products containing ephedra. He said he probably wouldn't have used the drug if he knew the risk involved.

Gibbons lost 15 pounds before the 2002 season while taking Xenadrine RFA-1. But he said he's sworn off the drug in the wake of Bechler's death and the Food and Drug Administration's effort to have stronger warning labels placed on ephedra-based products.

Bechler, 23, died of heatstroke on Feb. 17, one day after collapsing during a spring training workout.